Curis, Inc. Secures $80.8 Million Through Successful Private Placement Financing#United_States#Lexington#Private_Placement#emavusertib#Curis_Inc
Curis, Inc. Secures $80.8 Million Through Successful Private Placement Financing
Curis, Inc., a biotechnology firm, has successfully closed a private placement financing, raising up to $80.8 million to advance drug development.
third-news.com
January 9, 2026 at 1:17 PM
Curis, Inc. Secures $80.8 Million Through Successful Private Placement Financing#United_States#Lexington#Private_Placement#emavusertib#Curis_Inc
Curis Inc. Announces Inducement Grants to New Employees Under NASDAQ Guidelines#United_States#NASDAQ#Lexington#emavusertib#Curis_Inc.
Curis Inc. Announces Inducement Grants to New Employees Under NASDAQ Guidelines
Curis, Inc. has reported the grant of stock options to new employees in compliance with NASDAQ regulations, enhancing its workforce for future growth.
third-news.com
October 3, 2025 at 8:11 PM
Curis Inc. Announces Inducement Grants to New Employees Under NASDAQ Guidelines#United_States#NASDAQ#Lexington#emavusertib#Curis_Inc.